IGHS & KELO.CELL at CPHI Worldwide 2023

From October 24th to 26th, Barcelona was the heart of pharmaceutical innovation, bringing together the biggest industry players and over 50,000 professionals from more than 170 countries.

CPHI is the world's leading trade fair for the Pharma community and has become a key platform for new connections, strategic partnerships, exchanging knowledge and exploring new opportunities.

The event offers exhibitions, seminars, and other activities, all contributing to the global advancement of the pharmaceutical industry. This year’s CPhI Worldwide theme is 'Sustainability,' with different policies to minimize environmental impact, including the use of 100% renewable energy, minimization of disposable exhibition booths, and reduction of single-use plastics, to mitigate environmental impact.

IGHS Group, through its subsidiary INNOV-CELL THERAPEUTICS has marked its presence at the event, where had the opportunity to present the new KELO.CELL Product Line, which will be released on the market next month.

KELO.CELL Protect SPF30 is based on a unique and highly effective formulation with sun protection, specialy developed to enhance skin regeneration and improve the appearance of atrophic, hypertrophic and keloid scars, while protecting them from the sun damage.

KELO.CELL Concealer ensures instant coverage of scars and thanks to its special polymer is able to adapt to any skin tone.

Another innovation this year belongs to our PSORIS line, specially developed for psoriasis prone skin. KELO.CELL PSORIS SOS ACUTE BALM and KELO.CELL PSORIS BODY LOTION are designed to work together. They are essential allies to deal with skin conditions such as psoriasis or atopic dermatitis.

These were intensive days of work, presenting the quality and innovation of KELO.CELL brand, making many new connections and having interesting discussions.

IGHS's goal of opening doors to new collaboration and the creation of solutions with a positive impact on people’s health and well-being has been successfully achieved. In this way, reinforcing its commitment to innovation and excellence in the pharmaceutical industry.

• Innov.Cell ended its successful participation in CPHI 2024

  Innov.Cell, a subsidiary of IGHS, ended its successful participation in CPHI 2024, which took place in Milan, with a positive outcome. This year, CPHI was attended by more than 62,000 people and around 2,400 exhibitors from 166 countries. Throughout the event, Innov.Cell met with several potential partners, from R&D, investors, and distributors covering more than 50 countries.

  Read more
• OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)

  Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
   

  Read more